Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Palmar-plantar Erythrodysesthesia”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Not applicableStudy completedNCT02625415
What this trial is testing

The Topical Application of Vitamin B6 in Palmar-Plantar Erythrodysesthesia

Who this might be right for
Palmar-Plantar Erythrodysesthesia
Cyprus University of Technology 54
Early research (Phase 1)Ended earlyNCT00827580
What this trial is testing

Eniluracil Hand Foot Syndrome

Who this might be right for
Breast CancerColon Cancer
West Virginia University 3
Not applicableStudy completedNCT06832501
What this trial is testing

Effectiveness of the Henna Application in Patients With Hand-Foot Syndrome: Nested Case-Control Study

Who this might be right for
HennaHand-Foot SyndromeCase-Control Study
Hacettepe University 84
Large-scale testing (Phase 3)Ended earlyNCT00305643
What this trial is testing

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Who this might be right for
Breast CancerColorectal CancerPain
M.D. Anderson Cancer Center 11
Large-scale testing (Phase 3)Study completedNCT01918852
What this trial is testing

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.

Who this might be right for
Colorectal CancerMetastases
Dutch Colorectal Cancer Group 161
Not applicableNot Yet RecruitingNCT07501442
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of Uracil 0,5% Plasters in Oncology Patients Affected by Hand-foot Syndrome (HFS)

Who this might be right for
HFS
Wooshin Labottach Co., Ltd. 80
Not applicableStudy completedNCT00746694
What this trial is testing

Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)

Who this might be right for
Ovarian NeoplasmsBreast NeoplasmsParesthesia
Merck Sharp & Dohme LLC 154
Testing effectiveness (Phase 2)Ended earlyNCT00751101
What this trial is testing

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityPalmar-plantar Erythrodysesthesia
University of California, San Francisco 24
Not applicableStudy completedNCT02789137
What this trial is testing

Study On Fatigue- And Hand-Foot Syndrome-Related Quality Of Life In Patients With Metastatic Renal Cell Carcinoma Receiving A Tyrosine Kinase Inhibitor as First-Line Treatment

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 111
Not applicableStudy completedNCT06586073
What this trial is testing

Topical Cosmetic Products for Hand and Foot Syndrome

Who this might be right for
Hand Foot Skin Syndrome
Dermophisiologique s.r.l 53
Not applicableStudy completedNCT04592731
What this trial is testing

Acetylated Natural Nucleotides in Treating Hand-foot Syndrome

Who this might be right for
Hand-foot Syndrome
Nan xu 21
Testing effectiveness (Phase 2)Study completedNCT00213993
What this trial is testing

Topical Antiperspirant for Hand-Foot Syndrome

Who this might be right for
Palmar-plantar Erythrodysesthesia
University of Wisconsin, Madison 14
Not applicableUnknownNCT01291628
What this trial is testing

Prevention of Capecitabine Induced Hand and Foot Syndrome

Who this might be right for
Cancer
Rabin Medical Center 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07457671
What this trial is testing

TAR-0520 Gel in Hand and Foot Syndrome

Who this might be right for
Hand and Foot Syndrome
Tarian Pharma 25
Large-scale testing (Phase 3)Ended earlyNCT00486213
What this trial is testing

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Who this might be right for
Dermatologic ComplicationsPalmar-plantar ErythrodysesthesiaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Centre, Singapore 210
Not applicableLooking for participantsNCT06602167
What this trial is testing

Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome

Who this might be right for
CapecitabineHand-foot SyndromeElectroacupuncture+3 more
Affiliated Hospital of Qinghai University 220
Testing effectiveness (Phase 2)Study completedNCT00248248
What this trial is testing

DOXIL for Consolidation Therapy in Ovarian Cancer.

Who this might be right for
Ovarian Neoplasm
Southeastern Gynecologic Oncology 45
Not applicableStudy completedNCT05939726
What this trial is testing

Efficacy and Safety of Moisturising Cream With or Without Vitamin E and Urea Cream in Palmar-plantar Erythrodysesthesia

Who this might be right for
Palmar-Plantar ErythrodysesthesiaPalmar-Plantar Erythrodysesthesia Due to Cytotoxic Therapy
Sarawak General Hospital 145
Post-approval studies (Phase 4)Study completedNCT02961998
What this trial is testing

Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 116
Testing effectiveness (Phase 2)Study completedNCT01609166
What this trial is testing

Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome

Who this might be right for
Hand-foot Syndrome
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 60
Next Page